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Background: Because of its safety, relative low cost and widespread availability, conventional ultrasound (US) is the
modality of choice for initial evaluation of the liver. Following US, in patients eligible for surgery, further computed
tomography and/or magnetic resonance imaging is usually recommended for surgical planning. There are no
recent published series focusing on conventional abdominal US exclusively employed for the evaluation of liver
nodules before surgery. The objective of this study is to evaluate the efficacy of focused conventional preoperative
US in detecting liver lesions, and the impact of US findings on surgical management.
Methods: Sixty-seven noncirrhotic patients underwent surgical resection, after being previously submitted to
focused liver US evaluation. US results were compared with intraoperative US (IOUS) and histology (gold standard).
The IOUS was performed by the same radiologist who performed the preoperative US. Patient-by-patient and
lesion-by-lesion analyses were performed.
Results: A total of 241 lesions were depicted in 67 patients. The mean number of lesions detected per patient by
US and IOUS was 2.37 and 3.37, respectively (P = 0.001). In 52.2% of patients, US and IOUS depicted the same
number of liver lesions. Surgery with curative intent was conducted in 61 (91.0%) patients. Histological evaluation
was obtained in 196 lesions; 155 were considered malignant. The overall lesions detection rate by US was 65.6%.
For lesions <15 mm and lesions ≥15 mm, US showed a sensitivity rate of 55.3% and 75.5%, respectively.
Conclusions: The relatively high sensitivity rates achieved by US focused on liver evaluation, with the aim of
lowering costs but not efficiency, places the method in focus again for use in the routine preoperative staging of
candidates for liver resection. We suggest for preoperative evaluation that US could be associated with one section
imaging method (computed tomography or magnetic resonance imaging) as routine.
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Advances in imaging diagnosis, tumor staging, preopera-
tive and postoperative care and surgical techniques have
had a great impact on liver metastases resection in the
last years. This impact is particularly evident in patients
with colorectal cancer and neuroendocrine tumor metas-
tases, and in selected cases with other neoplasms [1-3].
Higher survival rates are related to complete removal of
hepatic metastases, and the success of the surgical treat-
ment highly depends on preoperative staging [4]. Several* Correspondence: ecmpnm@terra.com.br
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reproduction in any medium, provided the orimaging techniques are employed for preoperative staging
of the liver and, in clinical practice, ultrasound (US), com-
puted tomography (CT) and magnetic resonance imaging
(MRI) are currently used for that purpose.
Because of its safety, relative low cost and widespread
availability, conventional US is the modality of choice for
the initial evaluation of liver resection candidates, and can
be used to preclude from surgery patients with diffuse
lesions. Following US, in patients eligible for surgery, fur-
ther CT and/or MRI is usually recommended for surgical
planning [5].
Although many series have been published concerning
imaging diagnosis in focal liver lesions, mainly with CT
and MRI, the optimal imaging staging strategy has not yetLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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about the best imaging strategy for liver surgical planning.
Intraoperative ultrasound (IOUS) is well established as
the best imaging modality for liver lesion depiction and,
in some series, is considered the gold standard for liver
evaluation [6-8].
The real place for US in liver staging has not been
established. Besides the relevant advantages of US, there
are drawbacks related to the operator, patient and equip-
ment. As a result, US examination has a wide range of
sensitivity rates according to the published series. Low
sensitivity rates are usually related to studies performed
previous to state-of-the-art equipment and, there are no
recent published series focusing on conventional abdom-
inal US exclusively employed for the evaluation of liver
nodules before surgery.
This study seeks to determine whether US examin-
ation made exclusively for liver evaluation, using modern
equipment and operated by experienced radiologists,
may contribute to liver staging before hepatic resection.
In order to answer this question, the purpose of the
study was to evaluate the efficacy of conventional pre-
operative abdominal US in detecting liver lesions, and
the impact of US findings on surgical management.
Methods
Patients
From March 2002 to June 2007, 67 patients were stud-
ied. After being indicated for curative intent surgery by a
multidisciplinary team, patients were sent to the Imaging
Department for US liver evaluation.
Patients were included in this study if preoperative US
had been performed within 14 days before surgery and
cirrhotic patients were excluded. All patients were in-
formed about the study and signed an informed consent.
There were 34 men and 33 women, with a mean age of
57 years (range: 20 to 73 years). Diagnosis included colo-
rectal cancer metastasis (n = 51), neuroendocrine tumor
metastasis (n = 6), peripheral cholangiocarcinoma (n = 3),
gastrointestinal stromal tumor metastasis (n = 2), one
melanoma metastasis, one basal cell carcinoma metastasis,
one gastric cancer metastasis, one breast cancer metastasis
and one bladder cancer metastasis.
Ultrasound
US examination was performed using ATL HDI-5000
equipment (Philips Medical Systems, Bothel WA, USA)
with a convex 2 to 5 mHz probe and, when necessary, a
linear 5 to 12 mHz probe and Doppler duplex. US was
performed at the dorsal and left lateral decubitus, through
an intercostal and subcostal approach with a breath-hold
maneuver. Two experienced radiologists, not blind to pre-
vious clinical and radiologic data, performed the US and
gave the results in consensus.US findings were recorded by number, size and location
of the lesions. Typical hemangioma (<3 cm homogeneous
hyperechoic and well delimited) and cystic lesions (an-
echoic lumen, increased through transmission and well-
defined wall) were excluded from the analysis. Any lesion
not meeting those criteria was included in the analysis.
The number, size and location of liver lesions were
also recorded according to the IOUS and, for removed
liver segments, histological findings.
The lesion’s location was established according to the
Brisbane classification: left lateral section (Couinaud’s seg-
ments II and III), left medial section (Couinaud’s segment
IV), right anterior section (Couinaud’s segments V and
VIII) and right posterior section (Couinaud’s segments VI
and VII). Any lesion >40 mm or occupying more than one
of these segments was considered separately.
Surgical plan
The surgical plan was first established at the multidiscip-
linary meeting, and, if necessary, modified after the con-
ventional liver US. The definitive surgical strategy was
established after palpation and IOUS evaluation. The
IOUS was performed by the same radiologist who
performed the preoperative US, using Tosbee equipment
(Toshiba, Tokyo, Japan) with a T-shaped 7 mHz
intraoperative probe bound in sterile plastic.
Data analysis
Results were evaluated with reference to lesion-by-lesion
and patient-by-patient databases and US results were
compared with IOUS and histological evaluation results.
Histology was considered the gold standard.
Based on the patient-by-patient analysis, surgical plan-
ning changes were analyzed, and the total number and
mean number of lesions detected per patient by US and
by IOUS were compared (by Wilcoxon test and intra-
class correlation coefficient).
Based on lesion-by-lesion analysis, the sensitivity, spe-
cificity and positive predictive values were calculated for
US and IOUS using histological findings as the gold
standard. The agreement rate between US and IOUS
was calculated by the Kappa test.
Despite not being the main objective of the study, the
nonstandardized CT and MRI examinations previously car-
ried out were nevertheless analyzed and the results com-
pared with those of US, since the preoperative surgical
decision was based on them. Good quality examinations
made within 40 days before surgery were considered for
analysis: CT scans with multidetector or spiral equipment
with oral and intravenous iodine contrast acquired at pre-
contrast, arterial phase and portal venous phase with a
maximum of 5 mm thickness section were accepted. MRI
examinations acquired using high magnetic field equipment
with T1-weighted sections, before and after paramagnetic
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phase and out-of-phase sequences, and T2-weighted
images obtained with and without fat-saturation sequences
were accepted.Results
Patient-by-patient analysis
Sixty-seven patients were included in the study. The mean
number of lesions detected per patient by US and IOUS
was 2.37 and 3.37, respectively (P = 0.001; Figure 1). In
52.2% of patients, US and IOUS depicted the same num-
ber of liver lesions. In 4.5% of patients, US detected more
lesions than IOUS; and in 43.3% of patients, the IOUS
depicted from one to seven lesions in addition to the pre-
operative US results. The intra-class correlation index for
US and IOUS was 0.83 (P <0.001; Figure 2).
There was no statistically significant difference in the
number of lesions detected by US and by IOUS concerning
the presence of steatosis (in US or histology), prior chemo-
therapy or body mass index.
Surgery with curative intent was conducted in 61 (91%)
patients, including two IOUS-guided radiofrequency abla-
tions. In six patients, intraoperative findings precluded
liver resection; one of these patients had melanoma and
intraoperative inspection depicted diffuse peritoneal le-
sions not detected by previous US, CT or MRI. In three
patients there were hilar lymph node metastases; in an-
other patient, IOUS accurately identified hepatic veinFigure 1 Number of lesions detected per patient by ultrasound
and by intraoperative ultrasound. Mean and 95% confidence
interval (CI) for number of lesions detected per patient by
ultrasound (US) and by intraoperative ultrasound (IOUS).invasion, precluding resection. Vascular invasion suspicion
had already been depicted by the preoperative US. In the
last patient, US identified diffuse small liver lesions while
CT detected two lesions and positron emission tomog-
raphy–CT identified only one uptake lesion. Because of
these conflicting results, the patient underwent surgical
exploration that confirmed preoperative US findings, pre-
cluding resection.
The surgical plan, based on previous imaging examina-
tions (CT and/or MRI and US), was modified in 17
(25.5%) patients after the IOUS. Most of these changes
consisted of a new strategy to the previous planned hepa-
tectomy (due to new or more precisely located lesions
given by IOUS).
Lesion-by-lesion analysis
Two-hundred and forty-one lesions were depicted in 67
patients (mean 3.4; range 1 to 13 lesions per patient) with
a mean diameter of 24.1 mm (median 17 mm; range 2
to 120 mm).
Histological evaluation was obtained in 196 lesions; 155
were considered malignant (151 metastases and four liver
primary tumors) and 41 (20.9%) benign (Table 1).
Considering the 155 malignant lesions, 24.5% and 4.5%
were not depicted by US and by IOUS, respectively.
The overall lesion detection rate by US was 65.6% (158
of 241; 95% confidence interval: 62.2%, 74.0%), while by
nonstandardized CT the rate was 64.8% (46 of 72; 95%
confidence interval: 56.0%, 78.0%) and by nonstandardizedFigure 2 Intra-class correlation coefficient for number of
lesions detected per patient by ultrasound and intraoperative
ultrasound. Intra-class correlation coefficient (Ricc) for number of
lesions detected per patient by ultrasound (US) and by
intraoperative ultrasound (IOUS).
Table 1 Number of lesions according to histological
diagnosis
Histological diagnosis Number of lesions (%)
Metastases 151 (77.0)
Cholangiocarcinoma 3 (1.5)
Hepatocellular carcinoma 1 (0.5)
Normal liver 14 (7.1)
Steatosis 10 (5.1)
Fibrosis / necrosis (post chemotherapy) 13 (5.6)
Hyperplastic nodule 3 (1.5)
Hemangioma 1 (0.5)
Focal nodular hyperplasia 1 (0.5)
Biliary hematoma 1 (0.5)
Total 196 (100)
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59.9%, 61.3%).
Considering 196 lesions submitted to histological
evaluation, the sensitivity of US, IOUS, CT and MRI was
calculated taking into account the size of the lesions and
using histology as the gold standard (Table 2).
The sensitivity rates of imaging methods were lower
for lesions <15 mm, with a statistically significant differ-
ence (US: 55.3% × 75.5%, P = 0.005; CT: 33.3% × 75.5%,
P = 0.013; MRI: 31.5% × 63.6%, P = 0.039).
Indeed, for lesions <15 mm, US showed a higher sensi-
tivity rate when compared with the nonstandardized CT
and MRI examinations, although this was not statistically
significant (US, 55.3%; CT, 33.3%; MRI, 31.5%; P = 0.28
(US × CT) and P = 0.12 (US × MRI)).Discussion
Preoperative imaging techniques play an important role in
patient selection and surgical planning for liver resection.
According to several authors, US is recommended as the
first imaging method for liver lesion detection [9]. ForTable 2 Sensitivity of ultrasound, intraoperative




Imaging method All lesions Lesions <15 mm P value
Ultrasound 75.5 (196) 55.3 (96) 0.0050
Intraoperative ultrasound 95.5 (196) 92.3 (96) 0.5136
Computed tomography 75.5 (67) 33.3 (23) 0.0131
Magnetic resonance imaging 63.6 (55) 31.5 (26) 0.0391
Sensitivity using histological evaluation as the gold standard considering
separately all lesions and lesions <15 mm.further surgical planning, CT and MRI are the most fre-
quently employed imaging methods; however, there is no
agreement for the best preoperative approach. A multi-
modality strategy is therefore recommended, since no sin-
gle modality can accurately detect all liver tumors.
Although limitations related to equipment and operator
dependence are drawbacks for US examination, this
method yields important advantages due to lack of risks,
low cost and availability. Over the last 10 to 15 years, how-
ever, there have been few published studies focusing on
the efficacy of US on liver lesion detection or on its contri-
bution to liver resection strategy [5,9]. Furthermore, pub-
lished series describing low US sensitivity rates usually
rely on the use of nonstate-of-the-art equipment [10].
For more than one-half of the patients (52.2%) included
in this study, the same number of lesions was detected by
US and IOUS. Konopke and colleagues presented similar
results employing contrast-enhanced US, with 50% of
patients on their series with identical findings for both ex-
aminations [11]. These authors achieved lower sensitivity
rates for conventional US, comparable with our findings.
Higher sensitivity rates related to conventional US were
achieved by Dietrich and colleagues (84.6%) and Albrecht
and colleagues (71%). These authors used other imaging
methods, such as CT and MRI, rather than histology or
IOUS as the gold standard, which might have had an im-
pact on sensitivity rates [12,13].
The high sensitivity rate achieved by IOUS (95.5%)
and its higher lesion detection rate per patient when
compared with US are expected results according to
other studies [6-8]. In the present study, curative intent
surgery was achieved in 91% of patients, a result in ac-
cordance with other series, with 87 to 94.1% curative in-
tent surgery [14,15].
Although not the main objective of this study, non-
standardized CT and MRI were compared with US and
IOUS. We did not find any statistically significant differ-
ence between the sensitivity rates of these examinations
and preoperative US. While US was performed by two ex-
perienced radiologists using state-of-the-art equipment,
not blinded to previous imaging examinations, CT and
MRI scans were performed with nonstandardized proto-
cols or equipment. Indeed, although not ideal, the evalu-
ation of nonstandardized CT and MRI represents the daily
practice of a liver surgeon, who receives patients that have
already been submitted to radiological evaluation and,
based on these results, establishes the surgical plan. For
small hepatic lesions (<15 mm), US presented higher sen-
sitivity rates (55.3%) than CT (33.3%) and MRI (31.5%), al-
though no significant difference was observed.
Considering that multiple imaging studies are re-
commended for liver staging, Ward and colleagues sug-
gested that CT and MRI should both be employed
routinely on preoperative evaluation [16]. We suggest for
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one section imaging method (CT or MRI) as routine,
instead of the association of CT and MRI.
Conclusions
The relatively high sensitivity rates achieved by US
when performed by experienced radiologists and focus-
ing only on liver evaluation, with no significant differ-
ence when compared with nonstandardized CT and
MRI in the present series, places the method in focus
again for new studies, with the aim of lowing costs but
not the efficiency, in the routine preoperative staging of
liver resection candidates. This study confirms that the
best treatment option for a patient with a liver tumor is
to be studied by a specialized team and radiologist with
focused interest in liver tumors. The imaging method is
probably of secondary interest.
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